Late-stage chronic kidney disease (CKD) - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Late-stage chronic kidney disease (CKD) - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Late-stage chronic kidney disease (CKD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Late-stage chronic kidney disease (CKD) Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Late-stage chronic kidney disease (CKD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Late-stage chronic kidney disease (CKD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Late-stage chronic kidney disease (CKD) scenario.

Late-stage chronic kidney disease (CKD) Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Late-stage chronic kidney disease (CKD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Late-stage chronic kidney disease (CKD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Late-stage chronic kidney disease (CKD) Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Late-stage chronic kidney disease (CKD)

Key assessments

- Patient Segmentation in Late-stage chronic kidney disease (CKD)

- Late-stage chronic kidney disease (CKD) Risk & Burden

- Factors driving growth in a specific Late-stage chronic kidney disease (CKD) patient population

Late-stage chronic kidney disease (CKD) - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Late-stage chronic kidney disease (CKD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Late-stage chronic kidney disease (CKD) in 2016
2.2. Patient Share Distribution of Late-stage chronic kidney disease (CKD) in 2028
3. Disease Background and Overview: Late-stage chronic kidney disease (CKD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Late-stage chronic kidney disease (CKD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Late-stage chronic kidney disease (CKD) in 7MM - By Countries
5. Epidemiology of Late-stage chronic kidney disease (CKD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD)
5.1.3. Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) *
5.1.4. Sex- Specific Cases of the Late-stage chronic kidney disease (CKD)*
5.1.5. Diagnosed Cases of the Late-stage chronic kidney disease (CKD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD)
5.4.3. Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD)*
5.4.4. Sex- Specific Cases of the Late-stage chronic kidney disease (CKD)*
5.4.5. Diagnosed Cases of the Late-stage chronic kidney disease (CKD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD)
5.5.3. Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD)*
5.5.4. Sex- Specific Cases of the Late-stage chronic kidney disease (CKD)*
5.5.5. Diagnosed Cases of the Late-stage chronic kidney disease (CKD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD)
5.6.3. Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD)*
5.6.4. Sex- Specific Cases of the Late-stage chronic kidney disease (CKD)*
5.6.5. Diagnosed Cases of the Late-stage chronic kidney disease (CKD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD)
5.7.3. Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD)*
5.7.4. Sex- Specific Cases of the Late-stage chronic kidney disease (CKD)*
5.7.5. Diagnosed Cases of the Late-stage chronic kidney disease (CKD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD)
5.8.3. Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD)*
5.8.4. Sex- Specific Cases of the Late-stage chronic kidney disease (CKD)*
5.8.5. Diagnosed Cases of the Late-stage chronic kidney disease (CKD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD)
5.9.3. Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD)*
5.9.4. Sex- Specific Cases of the Late-stage chronic kidney disease (CKD)*
5.9.5. Diagnosed Cases of the Late-stage chronic kidney disease (CKD)
6. Unmet Needs of the Late-stage chronic kidney disease (CKD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in France (2016-2028) *
Table 14: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Late-stage chronic kidney disease (CKD) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Late-stage chronic kidney disease (CKD) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Late-stage chronic kidney disease (CKD) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Late-stage chronic kidney disease (CKD) in Japan (2016-2028)

  • Chronic Kidney Disease Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 137
    Chronic Kidney Disease Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Chronic Kidney Disease Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Chronic Kidney Disease Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 g......
  • Global Hemodialysis Concentrates Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 22-Jan-2020        Price: US 2980 Onwards        Pages: 109
    Snapshot The global Hemodialysis Concentrates market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Hemodialysis Concentrates by product, region and application, in addition, this report introduces market competition situation among the vend......
  • Global Hemodialysis Concentrates Market Data Survey Report 2015-2025
    Published: 21-Jan-2020        Price: US 1500 Onwards        Pages: 68
    Summary The global Hemodialysis Concentrates market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company pr......
  • IgA Nephropathy (IgAN) Market Insight, Epidemiology and Market Forecast - 2030
    Published: 16-Jan-2020        Price: US 6950 Onwards        Pages: 150
    DelveInsight's "IgA Nephropathy (IgAN) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the IgA Nephropathy (IgAN), historical and forecasted epidemiology as well as the IgA Nephropathy (IgAN) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The IgA Nephropathy (IgAN) market report provides current treatment practices, emerging drugs, IgA Nephropathy (IgAN) market share of the indi......
  • Diabetic Kidney Disease (DKD) Market Insight, Epidemiology and Market Forecast - 2030
    Published: 16-Jan-2020        Price: US 6950 Onwards        Pages: 150
    DelveInsight's "Diabetic Kidney Disease (DKD) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Diabetic Kidney Disease (DKD), historical and forecasted epidemiology as well as the Diabetic Kidney Disease (DKD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Kidney Disease (DKD) market report provides current treatment practices, emerging drugs, Diabetic Kidney Dis......
  • Distal Renal Tubular Acidosis (dRTA) - Market Insight, Epidemiology and Market Forecast - 2030
    Published: 16-Jan-2020        Price: US 6950 Onwards        Pages: 150
    DelveInsight's "Distal Renal Tubular Acidosis (dRTA) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Distal Renal Tubular Acidosis (dRTA), historical and forecasted epidemiology as well as the Distal Renal Tubular Acidosis (dRTA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Distal Renal Tubular Acidosis (dRTA) market report provides current treatment practices, emergin......
  • End - Stage Renal Disease (ESRD) Market Insight, Epidemiology and Market Forecast - 2030
    Published: 16-Jan-2020        Price: US 6950 Onwards        Pages: 150
    DelveInsight's "End-Stage Renal Disease (ESRD) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the End-Stage Renal Disease (ESRD), historical and forecasted epidemiology as well as the End-Stage Renal Disease (ESRD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The End-Stage Renal Disease (ESRD) market report provides current treatment practices, emerging drugs, End-Stage Renal......
  • Global Peritoneal Dialysis Solution Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 14-Jan-2020        Price: US 2980 Onwards        Pages: 91
    Snapshot The global Peritoneal Dialysis Solution market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Peritoneal Dialysis Solution by product, region and application, in addition, this report introduces market competition situation among th......
  • Global Hemodialysis Concentrates Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 09-Jan-2020        Price: US 3480 Onwards        Pages: 139
    Summary Market Overview The global Hemodialysis Concentrates market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 2605.7 million by 2025, from USD 2309.6 million in 2019. The Hemodialysis Concentrates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs